Showing 4 of 4 recruiting trials for “Malignant peritoneal mesothelioma”
PTC-Guided Therapy for Peritoneal Mesothelioma
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
👨⚕️ Yongkun Sun, Doctor, Cancer Institute and Hospital, Chinese Academy of Medical SciencesCancer📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06581549 ↗
Immune Microenvironment and Gene Expression Profiling in Mesothelioma
👨⚕️ Giulia Pasello, MD, Istituto Oncologico Veneto IOV IRCCS📍 10 sites📅 Started Nov 2023View details ↗
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →